共 47 条
Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition
被引:286
作者:
Krawczyk, Przemek M.
[2
]
Eppink, Berina
[1
]
Essers, Jeroen
[1
,3
,4
]
Stap, Jan
[2
]
Rodermond, Hans
[5
,6
]
Odijk, Hanny
[1
]
Zelensky, Alex
[1
]
van Bree, Chris
[5
,6
]
Stalpers, Lukas J.
[7
]
Buist, Marrije R.
[8
]
Soullie, Thomas
[9
]
Rens, Joost
[9
]
Verhagen, Hence J. M.
[4
]
O'Connor, Mark J.
[10
]
Franken, Nicolaas A. P.
[5
,6
,7
]
ten Hagen, Timo L. M.
[9
]
Kanaar, Roland
[1
,3
]
Aten, Jacob A.
[2
]
机构:
[1] Erasmus MC, Dept Cell Biol & Genet, Canc Genom Ctr, NL-3000 CA Rotterdam, Netherlands
[2] Univ Amsterdam, Van Leeuwenhoek Ctr Adv Microscopy LCAM AMC, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands
[3] Erasmus MC, Dept Radiat Oncol, NL-3000 CA Rotterdam, Netherlands
[4] Erasmus MC, Dept Vasc Surg, NL-3000 CA Rotterdam, Netherlands
[5] Univ Amsterdam, Lab Expt Oncol & Radiobiol, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands
[6] Univ Amsterdam, Dept Radiotherapy, NL-1105 AZ Amsterdam, Netherlands
[7] Univ Amsterdam, Dept Radiat Oncol, NL-1105 AZ Amsterdam, Netherlands
[8] Univ Amsterdam, Acad Med Ctr, Dept Gynecol Oncol, NL-1105 AZ Amsterdam, Netherlands
[9] Erasmus MC, Dept Surg Oncol, NL-3000 CA Rotterdam, Netherlands
[10] AstraZeneca, Canc Biosci, Alderley Pk SK10 4TG, Cheshire, England
来源:
关键词:
anti-cancer treatment;
RAD51;
double-strand break;
SISTER-CHROMATID EXCHANGES;
DNA-DAMAGE;
THERMAL RADIOSENSITIZATION;
NUDE-MICE;
PHASE-I;
REPAIR;
MUTANT;
MECHANISM;
PATHWAYS;
COMBINATION;
D O I:
10.1073/pnas.1101053108
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
Defective homologous recombination (HR) DNA repair imposed by BRCA1 or BRCA2 deficiency sensitizes cells to poly (ADP-ribose) polymerase (PARP)-1 inhibition and is currently exploited in clinical treatment of HR-deficient tumors. Here we show that mild hyperthermia (41-42.5 degrees C) induces degradation of BRCA2 and inhibits HR. We demonstrate that hyperthermia can be used to sensitize innately HR-proficient tumor cells to PARP-1 inhibitors and that this effect can be enhanced by heat shock protein inhibition. Our results, obtained from cell lines and in vivo tumor models, enable the design of unique therapeutic strategies involving localized on-demand induction of HR deficiency, an approach that we term induced synthetic lethality.
引用
收藏
页码:9851 / 9856
页数:6
相关论文